Form 4 for KROS Keros Therapeutics, Inc.
Accepted 2021-11-12 00:00:00 ET · period of report 2021-11-10 · accession 0001209191-21-064218 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-12 | 2021-11-10+ | KROS | Lachey Jennifer | CSO | S - Sale+OE | $59.91 | -21.2K | 90.3K | -19% | -$1.27M |
| DM | 2021-11-12 | 2021-11-10+ | KROS | Lachey Jennifer | CSO | M - OptEx | $0.3 | +21.2K | 101.6K | +26% | +$6,360 |
| DM | 2021-11-12 | 2021-11-10+ | KROS | Lachey Jennifer | CSO | M - OptEx | $0.00 | -21.2K | 97.9K | -18% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-10 | S | D | 15,900 | $60.00 | 85,700 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-11 | M | A | 5,300 | $0.3 | 91,000 | D | — | — | |
| 3 | Common | Common Stock | 2021-11-10 | M | A | 15,900 | $0.3 | 101,600 | D | — | — | |
| 4 | Common | Common Stock | 2021-11-11 | S | D | 4,561 | $59.78 | 85,700 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.145 to $60.07 inclusive. |
| 5 | Common | Common Stock | 2021-11-11 | S | D | 739 | $58.73 | 90,261 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.125 to $59.03 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3). |
| 6 | Derivative | Employee Stock Option (right to buy) | 2021-11-10 | M | D | 15,900 | $0.00 | 103,205 | D | $0.3 · — to 2028-03-25 | 15,900 Common Stock | (F4) Immediately exercisable. |
| 7 | Derivative | Employee Stock Option (right to buy) | 2021-11-11 | M | D | 5,300 | $0.00 | 97,905 | D | $0.3 · — to 2028-03-25 | 5,300 Common Stock | (F4) Immediately exercisable. |